These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New developments in dideoxynucleoside antiretroviral therapy for HIV infection. Fischl MA AIDS Clin Rev; 1991; ():197-214. PubMed ID: 1651100 [No Abstract] [Full Text] [Related]
3. Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements. Gillespie D; Hubbell HR; Carter WA; Midgette P; Elsasser W; Mullaney R; Strayer DR In Vivo; 1994; 8(3):375-81. PubMed ID: 7803722 [TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues. Kamali F Clin Investig; 1993 May; 71(5):392-405. PubMed ID: 7685214 [TBL] [Abstract][Full Text] [Related]
5. New trials reach same conclusion: two drugs are better than AZT alone. AIDS Alert; 1995 Nov; 10(11):133-6. PubMed ID: 11362921 [TBL] [Abstract][Full Text] [Related]
7. Other AIDS drug regimens beat AZT alone, reduce clinical progression and mortality. Stephenson J JAMA; 1995 Oct; 274(15):1183-4. PubMed ID: 7563492 [No Abstract] [Full Text] [Related]
8. ACTG 175 and Delta. Torres G GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915 [TBL] [Abstract][Full Text] [Related]
9. Treatment of human immunodeficiency virus-infected infants and young children with dideoxynucleosides. Pizzo PA Am J Med; 1990 May; 88(5B):16S-19S. PubMed ID: 2159704 [TBL] [Abstract][Full Text] [Related]
11. Managing HIV disease after Delta. Pinching AJ BMJ; 1996 Mar; 312(7030):521-2. PubMed ID: 8595267 [No Abstract] [Full Text] [Related]
12. Anti-human immunodeficiency virus therapeutics: now and the future. Kahn J Semin Liver Dis; 1992 May; 12(2):121-7. PubMed ID: 1321986 [TBL] [Abstract][Full Text] [Related]
13. Study results at a glance. AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922 [TBL] [Abstract][Full Text] [Related]
14. Confirmation for combination AIDS therapy. Science; 1995 Oct; 270(5233):33. PubMed ID: 7569948 [No Abstract] [Full Text] [Related]
15. ACTG 175: new insights into treating patients with intermediate-stage HIV disease. Folkers G NIAID AIDS Agenda; 1995 Dec; ():4-5. PubMed ID: 11363352 [TBL] [Abstract][Full Text] [Related]
16. Therapy for human immunodeficiency virus infection -- what have we learned? Corey L; Holmes KK N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046 [No Abstract] [Full Text] [Related]
17. [Antiretroviral treatment. Present and future of the combinations]. Gatell-Artigas JM Rev Neurol; 1996 Dec; 24(136):1627-31. PubMed ID: 9064189 [TBL] [Abstract][Full Text] [Related]
18. Making sense of 175 and Delta. Smart T GMHC Treat Issues; 1995 Oct; 9(10):4. PubMed ID: 11362916 [TBL] [Abstract][Full Text] [Related]
19. Targets for antiviral therapy of human immunodeficiency virus infection. Jeffries DJ J Infect; 1989 Jan; 18 Suppl 1():5-13. PubMed ID: 2464649 [TBL] [Abstract][Full Text] [Related]
20. [Therapy of AIDS]. Wolff K; Stingl G Wien Med Wochenschr; 1988 Oct; 138(19-20):524-30. PubMed ID: 2849247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]